Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (171-180 of 429) with videos related to

Pageof 43
Sort By:
Science Translational Medicine|October 5, 2022
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fosYuan Liu, Neel Chudgar, Brooke Mastrogiacomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 13, 2022
Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization AnalysisYujia Lu, Yu Chen Zhao, Jenny Chang-Claude, et al.
Blood Advances|April 4, 2019
Germline deletion of <i>ETV6</i> in familial acute lymphoblastic leukemiaEvadnie Rampersaud, David S Ziegler, Ilaria Iacobucci, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Patient Education and Counseling|February 5, 2026
Adapting mainstreaming genetic education and clinical communication materials for cancer patients of varying backgroundsStephanie N Christian-Afflu, Rania Sheikh, Anna Strang, et al.
Cancer|October 28, 2022
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testingMelissa K Frey, Muhammad Danyal Ahsan, Nora Badiner, et al.
Pageof 43

Showing results (171-180 of 429) with videos related to

Sort By:
Pageof 43
Science Translational Medicine|October 5, 2022
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fosYuan Liu, Neel Chudgar, Brooke Mastrogiacomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2022
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndromeYing L Liu, Karen A Cadoo, Anna Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyAndrea Eisen, Jan Lubinski, Jan Klijn, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 13, 2022
Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization AnalysisYujia Lu, Yu Chen Zhao, Jenny Chang-Claude, et al.
Blood Advances|April 4, 2019
Germline deletion of <i>ETV6</i> in familial acute lymphoblastic leukemiaEvadnie Rampersaud, David S Ziegler, Ilaria Iacobucci, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Patient Education and Counseling|February 5, 2026
Adapting mainstreaming genetic education and clinical communication materials for cancer patients of varying backgroundsStephanie N Christian-Afflu, Rania Sheikh, Anna Strang, et al.
Cancer|October 28, 2022
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testingMelissa K Frey, Muhammad Danyal Ahsan, Nora Badiner, et al.
Pageof 43